Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JP6202893B2 - Method for evaluating the expression level of target protein in cells - Google Patents
[go: Go Back, main page]

JP6202893B2 - Method for evaluating the expression level of target protein in cells - Google Patents

Method for evaluating the expression level of target protein in cells Download PDF

Info

Publication number
JP6202893B2
JP6202893B2 JP2013127018A JP2013127018A JP6202893B2 JP 6202893 B2 JP6202893 B2 JP 6202893B2 JP 2013127018 A JP2013127018 A JP 2013127018A JP 2013127018 A JP2013127018 A JP 2013127018A JP 6202893 B2 JP6202893 B2 JP 6202893B2
Authority
JP
Japan
Prior art keywords
cell
cells
target protein
enzyme
expression level
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2013127018A
Other languages
Japanese (ja)
Other versions
JP2015001480A (en
Inventor
和孝 西川
和孝 西川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Olympus Corp
Original Assignee
Olympus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Olympus Corp filed Critical Olympus Corp
Priority to JP2013127018A priority Critical patent/JP6202893B2/en
Publication of JP2015001480A publication Critical patent/JP2015001480A/en
Application granted granted Critical
Publication of JP6202893B2 publication Critical patent/JP6202893B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Description

本発明は、酵素標識抗体を用いた免疫染色により、細胞の標的タンパク質発現量を評価する方法に関する。   The present invention relates to a method for evaluating a target protein expression level of a cell by immunostaining using an enzyme-labeled antibody.

細胞や組織の形態情報から患者を診断する細胞診や組織診断は、病理診断において重要な役割を果たす。例えば、組織診断ではヘマトキシリン・エオジン染色等、細胞診ではパパニコロウ染色やギムザ染色等の一般的な染色方法を用いて細胞を染色し、呈色した細胞の明視野での顕微鏡による形態観察から、細胞や核の形の異常の有無を識別する。   Cytodiagnosis and tissue diagnosis for diagnosing a patient from morphological information of cells and tissues play an important role in pathological diagnosis. For example, cells are stained using hematoxylin / eosin staining for tissue diagnosis, and general staining methods such as Papanicolaou staining and Giemsa staining for cytodiagnosis. And the presence or absence of abnormalities in the shape of the nucleus.

細胞における特定のタンパク質の発現を調べる方法としては、標的タンパク質と特異的に結合する抗体を用いた免疫染色を行う免疫染色法が一般的である。免疫染色法では、染色の有無や染色強度に基づいて、各細胞において当該標的タンパク質の発現の有無や発現強度を識別する。免疫染色には、酵素標識した抗体を用いる酵素抗体染色法と、蛍光標識した抗体を用いる蛍光抗体染色法とがあるが、高価な蛍光顕微鏡を必要としないことから、医療現場等では酵素抗体染色法が好まれる。   As a method for examining the expression of a specific protein in a cell, an immunostaining method in which immunostaining is performed using an antibody that specifically binds to a target protein is common. In the immunostaining method, the presence or absence and expression intensity of the target protein are identified in each cell based on the presence or absence of staining and the staining intensity. Immunostaining includes an enzyme antibody staining method using an enzyme-labeled antibody and a fluorescent antibody staining method using a fluorescently labeled antibody. However, since an expensive fluorescence microscope is not required, enzyme antibody staining is used in medical settings. Law is preferred.

形態情報と、病理マーカーとなる特定のタンパク質の発現情報との両方を組合せることにより、精度の高い病理診断が可能になる。形態観察のための色素染色と、解析対象である標的タンパク質の発現を調べる免疫染色は、いずれも検体中の細胞を染色する方法であり、同一の標本を二重に染色した場合には呈色が重なってしまうため、染色強度を正確に比較することができず、標本中の各細胞について標的タンパク質の発現量を評価することは非常に難しい。そこで、一般的には、色素染色と免疫染色にはそれぞれ別個の病理標本を用いる。同一の標本に対して両方の染色を実施する場合は、細胞転写法等により標本を2つに切り分け(例えば、非特許文献1参照。)、一方を色素染色し、他方を免疫染色することにより、呈色の混合が避けられている。   Combining both the morphological information and the expression information of a specific protein serving as a pathological marker enables highly accurate pathological diagnosis. Both dye staining for morphological observation and immunostaining for examining the expression of the target protein to be analyzed are methods for staining cells in a specimen. Coloring occurs when the same specimen is stained twice. Therefore, it is very difficult to evaluate the expression level of the target protein for each cell in the specimen. In general, therefore, separate pathological specimens are used for dye staining and immunostaining. When both stainings are performed on the same specimen, the specimen is divided into two by a cell transfer method or the like (for example, see Non-Patent Document 1), one is dyed, and the other is immunostained. , Color mixing is avoided.

その他、細胞の蛍光画像を取りながら、カルシウムイオン濃度の変化をリアルタイムで測定し、画像の位置と時系列信号とを対応付ける装置が知られている。(例えば、特許文献1参照)。このような装置を応用すれば、免疫染色を蛍光抗体染色法により行うことによって、細胞の形態情報と分子情報とを合わせて得ることができる。   In addition, there is known an apparatus that measures a change in calcium ion concentration in real time while taking a fluorescence image of a cell, and associates the position of the image with a time-series signal. (For example, refer to Patent Document 1). If such an apparatus is applied, cell morphology information and molecular information can be obtained together by performing immunostaining by a fluorescent antibody staining method.

特開2006−3154号公報JP 2006-3154 A

細胞検査士会編集、「細胞診標本作製マニュアル」、2008年、第19〜20ページ。Edited by Cytologists Association, “Cytology Preparation Manual”, 2008, pages 19-20.

形態情報と標的タンパク質の発現情報は、同一の細胞に対して取得することが好ましい。しかしながら、同一の検体標本に対して色素染色と免疫染色の両方を行った場合には、色素染色がバックグラウンドとなり、免疫染色による呈色強度の正確な画像解析ができず、標的タンパク質の発現情報の信頼性が低いという問題がある。
一方で、細胞転写法等により一の標本を2以上に分ける方法もあるが、当該方法は操作が煩雑であり、手間がかかる上に、標本の種類や状態によってはそもそも転写不可能な場合もある。
The morphological information and the expression information of the target protein are preferably acquired for the same cell. However, when both dye staining and immunostaining are performed on the same specimen, dye staining becomes the background, and accurate image analysis of color intensity by immunostaining cannot be performed, and target protein expression information There is a problem of low reliability.
On the other hand, there is a method of dividing one specimen into two or more by a cell transfer method or the like, but this method is cumbersome and time-consuming, and it may be impossible to transfer depending on the type and state of the specimen. is there.

本発明は、酵素標識抗体を用いた免疫染色において、色素染色との二重染色を行った細胞のように、当該酵素標識抗体の酵素反応による発色以外の色がバックグラウンドとなる細胞についても、標的タンパク質発現量を精度よく評価し得る方法を提供することを目的とする。   In the immunostaining using an enzyme-labeled antibody, the present invention is similar to cells that have been double-stained with a dye stain. It aims at providing the method which can evaluate a target protein expression level accurately.

本発明者は、上記課題を解決すべく鋭意研究した結果、酵素標識抗体法において、経時的な発色強度(呈色強度)の変化を指標とすることにより、酵素反応以外による染色由来の色がバックグラウンドとなる細胞画像からも、酵素反応による呈色強度の正確な画像解析が可能であることを見出し、本発明を完成させた。   As a result of diligent research to solve the above-mentioned problems, the present inventor uses the enzyme-labeled antibody method to change the color development intensity (coloration intensity) over time, so that the color derived from staining other than the enzymatic reaction can be changed. From the cell image as a background, it was found that accurate image analysis of color intensity by enzyme reaction was possible, and the present invention was completed.

すなわち、本発明に係る細胞の標的タンパク質の発現量の評価方法は、下記[1]〜[]である。
[1] (a)細胞試料中の細胞に対して、標的タンパク質と特異的に結合する酵素標識抗体又は酵素標識抗体複合体を用いた抗原抗体反応を行う工程と、
(b)前記工程(a)の後、前記細胞試料中の細胞に発色基質を加えて、酵素反応により発色させる工程と、
(c)前記工程(b)中、発色基質添加直後の時点を含む、発色基質添加後の少なくとも2以上の時点において、前記細胞試料中の細胞の透過光画像を取得する工程と、
(d)前記工程(c)において取得した2以上の透過光画像に基づき、各細胞における透過率の経時的変化を調べる工程と、
(e)前記工程(d)において求めた透過率の経時的変化に基づき、各細胞の前記標的タンパク質の発現量を評価する工程と、
を有し、前記工程(d)において、透過率の経時的変化を、透過率の変化量が予め規定された一定量に達するために要する酵素反応時間として求めることを特徴とする、細胞の標的タンパク質の発現量の評価方法。
[2] (a)細胞試料中の細胞に対して、標的タンパク質と特異的に結合する酵素標識抗体又は酵素標識抗体複合体を用いた抗原抗体反応を行う工程と、
(b)前記工程(a)の後、前記細胞試料中の細胞に発色基質を加えて、酵素反応により発色させる工程と、
(c)前記工程(b)中、発色基質添加直後の時点を含む、発色基質添加後の少なくとも2以上の時点において、前記細胞試料中の細胞の透過光画像を取得する工程と、
(d)前記工程(c)において取得した2以上の透過光画像に基づき、各細胞における透過率の経時的変化を調べる工程と、
(e)前記工程(d)において求めた透過率の経時的変化に基づき、各細胞の前記標的タンパク質の発現量を評価する工程と、
を有し、
前記工程(d)において、透過率の経時的変化を、透過率当たりの酵素反応時間変化率として求めることを特徴とする細胞の標的タンパク質の発現量の評価方法。
] 前記工程(b)の前に、前記細胞試料中の細胞が、色素により染色されている、前記[1]または[2]に記載の細胞の標的タンパク質の発現量の評価方法。
] 前記透過率が、画像の階調数として表される、前記[1]または[2]に記載の細胞の標的タンパク質の発現量の評価方法。
That is, the method for evaluating the expression level of the target protein in the cell according to the present invention is the following [1] to [ 4 ].
[1] (a) performing an antigen-antibody reaction using an enzyme-labeled antibody or enzyme-labeled antibody complex that specifically binds to a target protein on cells in a cell sample;
(B) after the step (a), adding a chromogenic substrate to the cells in the cell sample and causing a color to develop by an enzymatic reaction;
(C) obtaining a transmitted light image of cells in the cell sample at at least two or more time points after the addition of the chromogenic substrate, including the time point immediately after the addition of the chromogenic substrate in the step (b);
(D) based on two or more transmitted light images acquired in the step (c), examining the change over time of the transmittance in each cell;
(E) a step of evaluating the expression level of the target protein in each cell based on the change over time of the transmittance determined in the step (d);
Have a, in the step (d), the time course of the transmittance, the amount of change in transmittance and obtaining as an enzyme reaction time required to reach a predefined constant amount, the target cell A method for evaluating the expression level of a protein.
[2] (a) performing an antigen-antibody reaction using an enzyme-labeled antibody or enzyme-labeled antibody complex that specifically binds to a target protein on cells in a cell sample;
(B) after the step (a), adding a chromogenic substrate to the cells in the cell sample and causing a color to develop by an enzymatic reaction;
(C) obtaining a transmitted light image of cells in the cell sample at at least two or more time points after the addition of the chromogenic substrate, including the time point immediately after the addition of the chromogenic substrate in the step (b);
(D) based on two or more transmitted light images acquired in the step (c), examining the change over time of the transmittance in each cell;
(E) a step of evaluating the expression level of the target protein in each cell based on the change over time of the transmittance determined in the step (d);
Have
A method for evaluating the expression level of a target protein in a cell, wherein, in the step (d), a change in permeability over time is determined as a rate of change in enzyme reaction time per permeability.
[ 3 ] The method for evaluating the expression level of a target protein in a cell according to [1] or [2] , wherein the cells in the cell sample are stained with a dye before the step (b).
[ 4 ] The method for evaluating the expression level of a target protein in a cell according to [1] or [2], wherein the transmittance is expressed as the number of gradations of an image.

本発明に係る細胞の標的タンパク質の発現量の評価方法により、酵素抗体染色法を用いて、酵素標識抗体の酵素反応以外による呈色をバックグラウンドとして有する細胞についても、標的タンパク質の発現量を精度よく評価することができる。このため、当該方法により、例えば、形態観察用の色素染色との二重染色が行われた細胞試料についても、標的タンパク質の発現量の異なる細胞を識別することができる。   According to the method for evaluating the expression level of a target protein in a cell according to the present invention, the expression level of the target protein can be accurately determined even for cells having a coloration other than the enzyme reaction of the enzyme-labeled antibody using the enzyme antibody staining method as a background. Can be evaluated well. For this reason, for example, cells with different expression levels of the target protein can be identified even for cell samples that have been subjected to double staining with dye staining for morphology observation.

実施例1において、各細胞標本について取得された透過光画像を示す。In Example 1, the transmitted light image acquired about each cell sample is shown. 実施例1において、各細胞について、酵素反応時間ごとの階調数をプロットした図を示す。In Example 1, the figure which plotted the number of gradations for every enzyme reaction time about each cell is shown.

本発明に係る細胞の標的タンパク質の発現量の評価方法(以下、「本発明に係る発現量評価方法」ということがある。)は、酵素抗体染色法による染色の有無や染色強度に基づいて、個々の細胞の標的タンパク質の発現量を評価する方法であって、下記工程(a)〜(e)を有することを特徴とする。
(a)細胞試料中の細胞に対して、標的タンパク質と特異的に結合する酵素標識抗体又は酵素標識抗体複合体を用いた抗原抗体反応を行う工程と、
(b)前記工程(a)の後、前記細胞試料中の細胞に発色基質を加えて、酵素反応により発色させる工程と、
(c)前記工程(b)中、発色基質添加直後の時点を含む、発色基質添加後の少なくとも2以上の時点において、前記細胞試料中の細胞の透過光画像を取得する工程と、
(d)前記工程(c)において取得した2以上の透過光画像に基づき、各細胞における透過率の経時的変化を調べる工程と、
(e)前記工程(d)において求めた透過率の経時的変化に基づき、各細胞の前記標的タンパク質の発現量を評価する工程。
The method for evaluating the expression level of a target protein of a cell according to the present invention (hereinafter sometimes referred to as “expression level evaluation method according to the present invention”) is based on the presence or absence of staining by the enzyme antibody staining method and the staining intensity. A method for evaluating the expression level of a target protein in each cell, comprising the following steps (a) to (e).
(A) performing an antigen-antibody reaction using an enzyme-labeled antibody or enzyme-labeled antibody complex that specifically binds to a target protein on cells in a cell sample;
(B) after the step (a), adding a chromogenic substrate to the cells in the cell sample and causing a color to develop by an enzymatic reaction;
(C) obtaining a transmitted light image of cells in the cell sample at at least two or more time points after the addition of the chromogenic substrate, including the time point immediately after the addition of the chromogenic substrate in the step (b);
(D) based on two or more transmitted light images acquired in the step (c), examining the change over time of the transmittance in each cell;
(E) A step of evaluating the expression level of the target protein in each cell based on the change over time of the transmittance determined in the step (d).

本発明に係る発現量評価方法に供される細胞試料としては、例えば、生体試料(生物から採取された試料)や、生体試料から分離された細胞、生体試料から分離された細胞の培養物、及び培養細胞の培養物等が挙げられる。生体試料としては、生体から採取された組織片、血液、リンパ液、骨髄液、腹水、滲出液、羊膜液、喀痰、唾液、精液、胆汁、膵液、尿等の体液、糞便、腸管洗浄液、肺洗浄液、気管支洗浄液、又は膀胱洗浄液等が挙げられる。また、生体試料から分離された細胞としては、例えば、血液から分離回収された単核球成分(バッフィーコート)、リンパ液等から分離回収された細胞成分、組織片の結合組織を分解して細胞をばらばらにした溶液、組織片をばらばらにした後に分離回収された細胞成分等が挙げられる。なお、組織片の生体からの採取方法は特に限定されず、バイオプシー検体、手術サンプル等が挙げられる。本発明において供される細胞試料としては、標的タンパク質の発現量が異なる2種類以上の細胞が含まれているものが好ましく、生体試料や生体試料から分離された細胞等がより好ましく、組織標本中の細胞がさらに好ましい。   Examples of cell samples used in the expression level evaluation method according to the present invention include biological samples (samples collected from living organisms), cells separated from biological samples, cultures of cells separated from biological samples, And cultures of cultured cells. Biological samples include tissue fragments collected from living organisms, blood, lymph, bone marrow, ascites, exudates, amniotic fluid, sputum, saliva, semen, bile, pancreatic juice, urine and other body fluids, feces, intestinal lavage fluid, and lung lavage fluid , Bronchial lavage fluid, or bladder lavage fluid. Examples of cells separated from biological samples include mononuclear cell components (buffy coat) separated and collected from blood, cell components separated and collected from lymph, etc. Examples include separated solutions, cell components separated and recovered after the tissue pieces are separated. In addition, the collection | recovery method from the biological body of a tissue piece is not specifically limited, A biopsy specimen, a surgical sample, etc. are mentioned. The cell sample provided in the present invention preferably contains two or more types of cells with different expression levels of the target protein, more preferably a biological sample, a cell separated from the biological sample, etc. Are more preferred.

本発明において供される細胞試料としては、少なくとも工程(b)の前(酵素反応の前)に、好ましくは工程(a)の抗原抗体反応を行う前に、色素染色がなされているものが特に好ましい。当該色素染色としては、組織観察や細胞形態観察のための病理での一般的な染色が好ましい。具体的には、ヘマトキシリン・エオジン染色(HE染色)、パパニコロウ染色、ギムザ染色等が好適に用いられる。   As the cell sample provided in the present invention, a cell sample that has been dyed at least before step (b) (before the enzyme reaction), preferably before performing the antigen-antibody reaction in step (a) is particularly preferable. preferable. The dye staining is preferably general staining in pathology for tissue observation or cell morphology observation. Specifically, hematoxylin / eosin staining (HE staining), Papanicolaou staining, Giemsa staining and the like are preferably used.

標的タンパク質の存在量が多いほど、免疫染色による染色強度は強くなる。このため、免疫染色のみを行った細胞においては、免疫染色における染色強度を比較することにより、各細胞における標的タンパク質の発現強度を比較することができる。免疫染色された細胞の透過光画像においては、染色強度は透過率に反映され、染色強度が強い部位ほど、透過率が小さくなる。   The greater the amount of target protein present, the stronger the staining intensity by immunostaining. For this reason, in the cell which performed only immunostaining, the expression intensity | strength of the target protein in each cell can be compared by comparing the staining intensity | strength in immunostaining. In the transmitted light image of the immunostained cell, the staining intensity is reflected in the transmittance, and the transmittance is smaller as the staining intensity is higher.

ただし、色素により染色されている細胞をさらに酵素抗体染色法により染色した場合には、酵素反応による呈色領域と色素染色による呈色領域が重なる領域では、両者の色が重なってしまう結果、透過光画像からは、酵素反応による呈色と色素染色による呈色とを区別することはできない。つまり、色素染色との二重染色をした細胞では、酵素反応後の透過光画像における染色強度は標的タンパク質の発現量を正確に反映しておらず、当該透過光画像から各細胞の標的タンパク質の発現量を評価できない。これに対して、本発明に係る発現量評価方法では、透過光画像における透過率(染色強度)ではなく、透過率の経時的変化を指標とするため、色素染色がなされている細胞についても、精度よく標的タンパク質の発現量を評価することができる。   However, when cells stained with a dye are further stained with an enzyme antibody staining method, the color of the colored region due to the enzyme reaction and the colored region due to the dye staining overlap with each other. From the light image, it is not possible to distinguish between coloration due to enzyme reaction and coloration due to dye staining. In other words, in cells that have been double-stained with dye staining, the staining intensity in the transmitted light image after the enzyme reaction does not accurately reflect the expression level of the target protein. The expression level cannot be evaluated. On the other hand, in the expression level evaluation method according to the present invention, not the transmittance (staining intensity) in the transmitted light image but the change over time of the transmittance as an index, so for the cells that are dye-stained, The expression level of the target protein can be evaluated with high accuracy.

まず、工程(a)として、細胞試料中の細胞に対して、抗原抗体反応を利用して、標的タンパク質を酵素で標識する。標的タンパク質を標識する酵素としては、酵素抗体染色法において使用可能ないずれの酵素であってもよい。当該酵素としては、ペルオキシダーゼ又はフォスファターゼが、汎用されており好ましい。   First, as a step (a), a target protein is labeled with an enzyme using an antigen-antibody reaction to cells in a cell sample. The enzyme that labels the target protein may be any enzyme that can be used in the enzyme antibody staining method. As the enzyme, peroxidase or phosphatase is widely used and preferable.

標的タンパク質の酵素標識は、標的タンパク質と特異的に結合する抗体(一次抗体)を直接酵素標識した酵素標識抗体(酵素標識一次抗体)を用いて行ってもよく、一次抗体と、当該一次抗体に対して特異的に結合する抗体(二次抗体)を酵素標識した酵素標識二次抗体とを用いて行ってもよい。後者の場合、標的タンパク質は、一次抗体と酵素標識二次抗体との複合体により標識される。さらに、一次抗体と、ビオチン標識した二次抗体(ビオチン標識二次抗体)と、酵素標識したストレプトアビジン(又は、酵素標識したアビジン)を用い、これらの複合体により標的タンパク質を酵素標識してもよい。なお、本発明において、「酵素標識抗体複合体」には、一次抗体と酵素標識二次抗体との複合体と、一次抗体とビオチン標識二次抗体と酵素標識したストレプトアビジン(又は、酵素標識したアビジン)との複合体のいずれも含まれる。   Enzyme labeling of the target protein may be performed using an enzyme-labeled antibody (enzyme-labeled primary antibody) obtained by directly enzyme-labeling an antibody that specifically binds to the target protein (primary antibody). Alternatively, an enzyme-labeled secondary antibody obtained by enzyme-labeling an antibody that specifically binds to the antibody (secondary antibody) may be used. In the latter case, the target protein is labeled with a complex of a primary antibody and an enzyme-labeled secondary antibody. Furthermore, even if a target protein is enzyme-labeled with these complexes using a primary antibody, a biotin-labeled secondary antibody (biotin-labeled secondary antibody), and enzyme-labeled streptavidin (or enzyme-labeled avidin). Good. In the present invention, the “enzyme-labeled antibody complex” includes a complex of a primary antibody and an enzyme-labeled secondary antibody, and a streptavidin (or enzyme-labeled) that is enzyme-labeled with a primary antibody and a biotin-labeled secondary antibody. Any of the complexes with avidin) are included.

一次抗体や二次抗体として用いられる抗体は、モノクローナル抗体であってもよく、ポリクローナル抗体であってもよい。また、このような抗体は、市販の抗体を用いてもよく、抗原をマウスやラット、ウサギ等の実験動物に免疫し、常法により作製した抗体を用いてもよい。   The antibody used as the primary antibody or secondary antibody may be a monoclonal antibody or a polyclonal antibody. Such antibodies may be commercially available antibodies, or antibodies prepared by immunizing laboratory animals such as mice, rats, rabbits and the like with conventional methods.

標的タンパク質の酵素標識は、常法により行うことができる。例えば、まず、細胞試料中の細胞を、透過光による顕微鏡観察(明視野)が可能な細胞観察用容器に固定させ、次いで、この固定された細胞に、酵素標識一次抗体や、一次抗体と酵素標識二次抗体等を、一度に、又は必要に応じて順次接触させることにより、当該細胞が有する標的タンパク質を酵素標識する。複数の抗体等を順次接触させる場合には、次の抗体を接触させる前に、PBS(リン酸緩衝生理食塩水)等による洗浄処理を行うことも好ましい。   Enzyme labeling of the target protein can be performed by conventional methods. For example, first, cells in a cell sample are fixed to a cell observation container that can be observed with a microscope using transmitted light (bright field), and then the enzyme-labeled primary antibody or primary antibody and enzyme are immobilized on the fixed cells. The target protein possessed by the cell is enzyme-labeled by bringing a labeled secondary antibody or the like into contact at a time or sequentially as necessary. When contacting a plurality of antibodies or the like sequentially, it is also preferable to perform a washing treatment with PBS (phosphate buffered saline) or the like before contacting the next antibody.

また、標的タンパク質が細胞内に存在する場合、一次抗体を接触させる前に、予め細胞試料に含まれている細胞に対して、浸透化処理を行うことも好ましい。浸透化処理により、細胞膜や核膜に穴を開け、抗体等が細胞内や核内に浸透しやすくなる。浸透化処理としては、界面活性剤溶液に細胞を浸漬させる処理等の常法が挙げられる。界面活性剤としては、TritonX−100やTween 20、NP−40、サポニン、ジギトニン等を用いることができる。   In addition, when the target protein is present in the cells, it is also preferable to perform permeabilization on the cells previously contained in the cell sample before contacting the primary antibody. By the permeabilization treatment, a hole is made in the cell membrane or the nuclear membrane, and the antibody or the like easily penetrates into the cell or nucleus. Examples of the permeabilization treatment include conventional methods such as treatment of immersing cells in a surfactant solution. As the surfactant, Triton X-100, Tween 20, NP-40, saponin, digitonin, or the like can be used.

細胞観察用容器としては、一般的に細胞染色に用いられるものであれば、特に限定されるものではないが、スライドガラス、又はマルチウェルプレートであることが好ましい。スライドガラス又はマルチウェルプレートを用いて、イメージングサイトメータ等を用いることにより、多数の検体も迅速かつ簡便に処理することが可能となる。   The cell observation container is not particularly limited as long as it is generally used for cell staining, but is preferably a slide glass or a multiwell plate. By using an imaging cytometer or the like using a slide glass or a multi-well plate, a large number of specimens can be processed quickly and easily.

細胞観察用容器への細胞の固定方法は、特に限定されるものではなく、常法により行うことができる。例えば、細胞観察用容器に接着させた細胞を、自然乾燥させてもよく、ホルムアルデヒド、パラホルムアルデヒド、グルタールアルデヒド、メタノール、エタノール、アセトン等の固定化処理液で処理してもよい。固定化処理液を用いて固定した場合には、固定処理後、固定化処理液を除去するため、PBS等で洗浄する。その他、一次抗体と反応させる前に、細胞を固定した細胞観察用容器を、スキムミルク含有PBS等を用いてブロッキングすることも好ましい。   The method for fixing cells to the cell observation container is not particularly limited, and can be performed by a conventional method. For example, the cells adhered to the cell observation container may be naturally dried, or may be treated with an immobilization treatment solution such as formaldehyde, paraformaldehyde, glutaraldehyde, methanol, ethanol, acetone, or the like. When the immobilization treatment solution is used for fixation, the immobilization treatment solution is washed with PBS or the like after the immobilization treatment to remove the immobilization treatment solution. In addition, before the reaction with the primary antibody, it is also preferable to block the cell observation container on which the cells are fixed using skim milk-containing PBS or the like.

次に、工程(b)として、酵素で標識した細胞に発色基質を加えて、酵素反応により発色させる。発色基質としては、酵素反応により化学的修飾を受けると、可視領域の特定の波長の透過率を変化させる発色物質が生成物として生じる化合物であればよい。発色物質は化学的・物理的・静電的に生成された箇所に沈着し、沈着箇所の透過率を変化させる色として、顕微鏡観察像から視覚的に認識することができる。例えば、ペルオキシダーゼの発色基質には、ジアミノベンジジン(DAB)、アミノエチルカルバゾール(AEC)、BCIP/NBT、ファーストレッド、ニューフクシン等が用いられる。   Next, as a step (b), a chromogenic substrate is added to the cells labeled with the enzyme, and color is developed by an enzymatic reaction. The chromogenic substrate may be any compound that, as a product, produces a chromogenic substance that changes the transmittance at a specific wavelength in the visible region when chemically modified by an enzymatic reaction. The color-developing material can be visually recognized from a microscopic observation image as a color that deposits on a chemically, physically, and electrostatically generated site and changes the transmittance of the deposited site. For example, diaminobenzidine (DAB), aminoethylcarbazole (AEC), BCIP / NBT, Fast Red, New Fuchsin, etc. are used as the color developing substrate for peroxidase.

本発明に係る発現量評価方法においては、工程(c)として、工程(b)における酵素反応中に、同一の細胞について、2以上の時点において透過光画像を取得する。取得する透過光画像のうち1枚は、発色基質添加直後の時点で取得する。なお、発色基質添加直後の時点の透過光画像に代えて、発色基質添加前の透過光画像を取得してもよい。透過光画像の取得時点は、酵素の種類、酵素反応の温度、発色基質の種類や濃度等を考慮して適宜調整できる。例えば、酵素反応の終了時点よりも初期のほうが、酵素量による反応の差が表れやすいことから、工程(c)において取得する複数の透過光画像のうち、少なくとも1枚は、発色基質添加時点(酵素反応開始時点)から0.5〜3分後に取得することが好ましい。   In the expression level evaluation method according to the present invention, as step (c), a transmitted light image is acquired at two or more time points for the same cell during the enzyme reaction in step (b). One of the transmitted light images to be acquired is acquired immediately after the addition of the chromogenic substrate. Instead of the transmitted light image immediately after the addition of the chromogenic substrate, a transmitted light image before the addition of the chromogenic substrate may be obtained. The acquisition time point of the transmitted light image can be appropriately adjusted in consideration of the type of enzyme, the temperature of the enzyme reaction, the type and concentration of the chromogenic substrate, and the like. For example, since the difference in reaction due to the amount of enzyme tends to appear earlier than the end point of the enzyme reaction, at least one of the plurality of transmitted light images acquired in step (c) is at the chromogenic substrate addition point ( It is preferable to obtain 0.5 to 3 minutes after the enzyme reaction start time).

具体的には、透過光画像を取得可能な撮像装置を備えた光学顕微鏡に、標的タンパク質を酵素標識した細胞が固定された細胞観察用容器を設置し、同一視野について、発色基質添加直後の時点を含む2以上の時点で透過光画像を取得する。当該光学顕微鏡としては、倍率20〜400倍程度の観察が可能な光学顕微鏡が好ましい。当該撮像装置としては、CCDカメラ等の細胞の撮像に通常用いられる撮像装置が用いられる。当該光学顕微鏡としては、さらに、取得した透過光画像に対して所定の画像解析処理を実施するための情報処理装置を備えていることも好ましい。   Specifically, an optical microscope equipped with an imaging device capable of acquiring a transmitted light image is installed with a cell observation container on which cells labeled with the target protein are enzyme-labeled. Transmitted light images are acquired at two or more points including. As the optical microscope, an optical microscope capable of observation at a magnification of about 20 to 400 times is preferable. As the imaging apparatus, an imaging apparatus that is normally used for imaging cells such as a CCD camera is used. The optical microscope preferably further includes an information processing apparatus for performing a predetermined image analysis process on the acquired transmitted light image.

工程(c)において取得した2以上の透過光画像に基づき、各細胞における透過率の経時的変化を調べ(工程(d))、求めた透過率の経時的変化に基づき、各細胞の前記標的タンパク質の発現量を評価する(工程(e))。透過率の経時的変化とは、換言すれば時間の経過に伴う色の変化である。以下に示すように、発色に伴う透過率の経時的変化は、標的タンパク質の発現量(細胞における存在量)に比例している。このため、透過率の経時的変化が大きい細胞ほど、標的タンパク質の発現量が多く、透過率の経時的変化が小さい細胞ほど、標的タンパク質の発現量が少ない。   Based on the two or more transmitted light images acquired in the step (c), the temporal change in transmittance in each cell is examined (step (d)), and the target of each cell is determined based on the obtained temporal change in transmittance. The expression level of the protein is evaluated (step (e)). The change in transmittance with time is, in other words, a change in color with the passage of time. As will be shown below, the change in transmittance with time associated with color development is proportional to the expression level of the target protein (abundance in cells). For this reason, the expression level of the target protein is larger as the cell has a larger change in permeability over time, and the expression level of the target protein is lower as the cell has a smaller change in permeability over time.

酵素標識免疫染色では、酵素標識抗体により、基質が反応して呈色が進行する。この反応は、下記式(1)で示される。式(1)中、Eは酵素、Sは基質、ESは酵素基質複合体、Pは呈色した基質を意味する。   In enzyme-labeled immunostaining, the substrate reacts with the enzyme-labeled antibody to cause color development. This reaction is represented by the following formula (1). In the formula (1), E means an enzyme, S means a substrate, ES means an enzyme substrate complex, and P means a colored substrate.

[E]を全酵素の濃度([E]=[E]+[S])、[S]を基質濃度、[E]をフリーの酵素濃度、kを反応速度定数とすると、酵素濃度([E])の時間変化は、下記式(2)で示される。 [E] 0 is the total enzyme concentration ([E] 0 = [E] + [S] 0 ), [S] is the substrate concentration, [E] is the free enzyme concentration, and k is the reaction rate constant. The time change of the concentration ([E]) is expressed by the following formula (2).

このとき、基質が大過剰の条件でSの変化が乏しい条件とすると、[S]は一定の値になるため、下記式(3)及び(4)となる。 At this time, assuming that the substrate is largely excessive and the change of S is poor, [S] is a constant value, and therefore, the following equations (3) and (4) are obtained.

透過率の時間変化は、呈色した基質濃度[P]の時間変化に比例する。ここで、基質濃度[P]の時間変化d[P]/dt=k[ES]であるから、下記式(5)となる。 The time change of the transmittance is proportional to the time change of the colored substrate concentration [P]. Here, since the time change d [P] / dt = k 3 [ES] of the substrate concentration [P], the following equation (5) is obtained.

呈色反応が開始し、酵素反応が定常状態に達したときを想定すると、[ES]の時間変化は小さくなっているため、下記式(6)と仮定できる。したがって、呈色反応の速度(v)は、下記式(7)となる。つまり、酵素標識免疫染色では、標的タンパク質の発現量は[E]と比例するため、呈色反応の速度、すなわち酵素反応時間における透過率の変化量は、標的タンパク質の発現量に比例する。 Assuming that the color reaction has started and the enzyme reaction has reached a steady state, the change in time of [ES] is small, so it can be assumed that the following equation (6) is satisfied. Therefore, the speed (v 0 ) of the color reaction is expressed by the following formula (7). That is, in the enzyme-labeled immunostaining, the expression level of the target protein is proportional to [E] 0, and thus the speed of the color reaction, that is, the amount of change in the transmittance during the enzyme reaction time is proportional to the expression level of the target protein.

一方で、基質過剰で変化がなく定常状態に達した条件では、基質濃度[P]は下記式(8)となる。   On the other hand, the substrate concentration [P] is represented by the following formula (8) under the condition that the substrate is excessive and does not change and reaches a steady state.

このため、[P]が一定の値P’に到達するときの酵素反応時間tは、下記式(9)であり、標的タンパク質の発現量と比例する[E]は、酵素反応時間に反比例する。逆に、一定の反応時間t’における[P]t=t’は、下記式(10)であり、標的タンパク質の発現量に比例する。 Therefore, the enzyme reaction time t when [P] reaches a certain value P ′ is the following formula (9), and [E] 0 proportional to the expression level of the target protein is inversely proportional to the enzyme reaction time. To do. Conversely, [P] t = t ′ at a constant reaction time t ′ is the following formula (10), which is proportional to the expression level of the target protein.

酵素反応による呈色は独立した化学反応であるため、上記比例関係は、バックグラウンドの染色の有無に関わらず維持される。このため、バックグラウンドを有する条件においても、酵素反応時間における透過率の変化量を比較することにより、標的タンパク質の発現量を比較することができる。   Since the coloration by the enzyme reaction is an independent chemical reaction, the proportional relationship is maintained regardless of the presence or absence of background staining. For this reason, even under conditions having a background, the expression level of the target protein can be compared by comparing the amount of change in permeability during the enzyme reaction time.

具体的には、透過率の時間変化率を比較することにより、各細胞の標的タンパク質発現量を評価できる。透過率の時間変化率は、例えば、各細胞について、透過率を縦軸に、酵素反応時間を横軸として、工程(c)で取得された2以上の透過光画像からそれぞれ求めた各細胞の透過率をプロットした場合に、各プロットについての近似直線の傾きとして求められる。   Specifically, the target protein expression level of each cell can be evaluated by comparing the time change rate of the transmittance. The rate of change in transmittance over time is, for example, for each cell, obtained from the two or more transmitted light images acquired in step (c), with the transmittance as the vertical axis and the enzyme reaction time as the horizontal axis. When the transmittance is plotted, the slope of the approximate line for each plot is obtained.

透過率の時間変化率が高い細胞ほど、標的タンパク質発現量が多く、透過率の時間変化率が低い細胞ほど、標的タンパク質発現量が少ないと評価できる。細胞種によって標的タンパク質の発現量が異なる場合には、透過率の時間変化率が同程度の細胞同士は、同種の細胞である可能性が高いと評価でき、透過率の時間変化率が大きく相違する細胞同士は異種の細胞同士である可能性が高いと評価できる。   It can be evaluated that a cell having a higher rate of change in permeability with time has a higher target protein expression level and a cell with a lower rate of change in permeability with time has a lower target protein expression level. If the expression level of the target protein varies depending on the cell type, it can be evaluated that cells with the same rate of change in permeability over time are likely to be the same type of cells, and the rate of change in permeability over time is greatly different. It can be evaluated that there is a high possibility that the cells to be treated are different types of cells.

また、予め規定された一定時間当たりの透過率の変化量を比較することによっても、標的タンパク質発現量を評価できる。例えば、異なる時点に取得された2枚の透過光画像を比較した場合に、この2枚の透過光画像における同一細胞の透過率の差分が、一定時間当たりの透過率の変化量といえる。所定時間当たりの透過率の変化量が高い細胞ほど、標的タンパク質発現量が多く、所定時間当たりの透過率の変化量が低い細胞ほど、標的タンパク質発現量が少ないと評価できる。   The target protein expression level can also be evaluated by comparing the amount of change in the transmittance per predetermined time. For example, when two transmitted light images acquired at different points in time are compared, the difference in the transmittance of the same cell in the two transmitted light images can be said to be the amount of change in the transmittance per fixed time. It can be evaluated that a cell with a higher amount of change in permeability per predetermined time has a higher target protein expression level, and a cell with a lower amount of change in permeability per predetermined time has a lower target protein expression level.

その他、上記式(9)に示すように、透過率の変化量が予め規定された一定量に達するために要する酵素反応時間を比較することによっても、標的タンパク質発現量を評価できる。透過率の変化量が所定量に達するために要する酵素反応時間が短いほど、標的タンパク質発現量が多く、当該酵素反応時間が長い細胞ほど、標的タンパク質発現量が少ないと評価できる。   In addition, as shown in the above formula (9), the target protein expression level can also be evaluated by comparing the enzyme reaction time required for the change amount of the transmittance to reach a predetermined amount. It can be evaluated that the shorter the enzyme reaction time required for the transmittance change amount to reach a predetermined amount, the larger the target protein expression amount, and the longer the enzyme reaction time, the smaller the target protein expression amount.

同様に、透過率当たりの酵素反応時間変化率を比較することにより、各細胞の標的タンパク質発現量を評価できる。透過率当たりの酵素反応時間変化率が小さいほど、標的タンパク質発現量が多く、透過率当たりの酵素反応時間変化率が大きい細胞ほど、標的タンパク質発現量が少ないと評価できる。透過率当たりの酵素反応時間変化率は、例えば、各細胞について、酵素反応時間を縦軸に、透過率を横軸として、工程(c)で取得された2以上の透過光画像からそれぞれ求めた各細胞の透過率をプロットした場合に、各プロットについての近似直線の傾きとして求められる。   Similarly, the target protein expression level of each cell can be evaluated by comparing the rate of change in enzyme reaction time per permeability. It can be evaluated that the target protein expression amount is larger as the enzyme reaction time change rate per transmittance is smaller, and the target protein expression amount is smaller as the enzyme reaction time change rate per transmittance is larger. The rate of change in enzyme reaction time per transmittance was determined, for example, for each cell from the two or more transmitted light images obtained in step (c), with the enzyme reaction time on the vertical axis and the transmittance on the horizontal axis. When the transmittance of each cell is plotted, it is obtained as the slope of the approximate straight line for each plot.

また、透過率の時間変化率と同様に、所定時間当たりの透過率の変化量、透過率の変化量が予め規定された一定量に達するために要する酵素反応時間、又は透過率当たりの酵素反応時間変化率を指標とした場合でも、これらの値が同程度の細胞同士は同種の細胞である可能性が高いと評価でき、これらの値が大きく相違する細胞同士は異種の細胞同士である可能性が高いと評価できる。   Similarly to the rate of change in transmittance over time, the amount of change in transmittance per predetermined time, the enzyme reaction time required for the amount of change in transmittance to reach a predetermined amount, or the enzyme reaction per transmittance Even when the rate of time change is used as an index, cells with similar values can be evaluated as highly likely to be the same type of cells, and cells with greatly different values can be different types of cells. It can be evaluated that the property is high.

各透過光画像において、各細胞における透過率は、各細胞の細胞像を構成する対象画素の色成分における階調データ(階調数)に基づいて算出される。具体的には、細胞の細胞像を構成する全画素の階調数値の平均値が、各細胞の階調数値であり、透過率の指標となる。   In each transmitted light image, the transmittance of each cell is calculated based on the gradation data (number of gradations) of the color component of the target pixel constituting the cell image of each cell. Specifically, the average value of the gradation values of all the pixels constituting the cell image of the cell is the gradation value of each cell and serves as a transmittance index.

色素染色した細胞に対して本発明に係る発現量評価方法を行うことにより、細胞の形態の重要な情報源となる色素染色像を、標的タンパク質の発現量を評価した同一の細胞について取得することができる。このため、例えば、病理標本において、疾患マーカーを標的タンパク質とすることにより、疾患に特有の細胞の形態変化の有無と疾患マーカーの発現の有無や発現量の多寡を調べることができる。これにより、組織染色と免疫染色を異なる細胞標本に対して行う従来法よりも、当該疾患の罹患可能性や発症の有無、重篤度等を精度よく評価することもできる。   By performing the expression level evaluation method according to the present invention on the dye-stained cells, a dye-stained image that is an important information source of the cell morphology is obtained for the same cells in which the expression level of the target protein is evaluated. Can do. For this reason, for example, in a pathological specimen, by using a disease marker as a target protein, it is possible to examine the presence or absence of morphological change of cells peculiar to the disease, the presence or absence of expression of the disease marker, and the amount of expression. Thereby, the morbidity, presence / absence, severity, etc. of the disease can be more accurately evaluated than the conventional method in which tissue staining and immunostaining are performed on different cell specimens.

次に実施例を示して本発明をさらに詳細に説明するが、本発明は以下の実施例に限定されるものではない。   EXAMPLES Next, although an Example is shown and this invention is demonstrated further in detail, this invention is not limited to a following example.

[実施例1]
前立腺癌細胞株(PC−3株)について、パパニコロウ染色した細胞標本について、増殖マーカーであるKi−67を標的タンパク質として本発明に係る発現量評価方法を行った。
まず、細胞培養容器のガラスボトム上に接着させて培養したPC−3株を、4容量%パラホルムアルデヒド溶液で30分間処置し、固定した。蒸留水で洗浄した後、当該スライドガラス上の細胞をヘマトキシリン(メルク社製、製品番号:1092490500)で染色した。染色後の細胞は、蒸留水で洗浄した後、0.5容量%のTriton X−100溶液に5分間浸漬させた。その後、PBSで2度洗浄した後、当該ガラスボトム上の細胞を、Dako Real peroxidase Blocking solution(Dako社製、製品番号:S202386)に10分間浸漬させてブロッキング処理した。ブロッキング処理したガラスボトムは、PBSで2度洗浄した後、5容量%のヤギ血清含有PBSに30分間浸漬させた。次いで、当該ガラスボトム上の細胞に、Ki−67に対する一次抗体(Dako社製、製品番号:M724029)を室温で30分間反応させた。反応後、PBSで2度洗浄した後、酵素標識二次抗体(Dako社製、製品番号:K1390)を室温で30分間反応させ、反応後にPBSで2度洗浄した(サンプル)。
[Example 1]
For the prostate cancer cell line (PC-3 line), the expression level evaluation method according to the present invention was performed on a Papanicolaou-stained cell specimen using Ki-67 as a growth marker as a target protein.
First, the PC-3 strain adhered to the glass bottom of the cell culture vessel and cultured was treated with a 4% by volume paraformaldehyde solution for 30 minutes and fixed. After washing with distilled water, the cells on the slide glass were stained with hematoxylin (Merck, product number: 10924490500). The stained cells were washed with distilled water and then immersed in a 0.5% by volume Triton X-100 solution for 5 minutes. Then, after washing twice with PBS, the cells on the glass bottom were immersed in Dako Real peroxidase Blocking solution (manufactured by Dako, product number: S202386) for 10 minutes for blocking treatment. The blocked glass bottom was washed twice with PBS and then immersed in PBS containing 5% by volume of goat serum for 30 minutes. Next, the cells on the glass bottom were reacted with a primary antibody against Ki-67 (Dako, product number: M724029) at room temperature for 30 minutes. After the reaction, the plate was washed twice with PBS, and then an enzyme-labeled secondary antibody (manufactured by Dako, product number: K1390) was reacted at room temperature for 30 minutes, and after the reaction, washed twice with PBS (sample).

ヘマトキシリン染色を行わなかった以外は、上記と同様の処置を施した細胞標本をポジティブコントロールとし、ヘマトキシリン染色を行わず、かつKi−67に対する一次抗体を添加しなかった以外は、上記と同様の処置を施した細胞標本をネガティブコントロールとした。   A treatment similar to the above except that the cell sample treated as above was used as a positive control, except that hematoxylin staining was not performed, hematoxylin staining was not performed, and no primary antibody against Ki-67 was added. The cell sample subjected to was used as a negative control.

その後、各細胞標本の細胞培養容器を、撮像装置(オリンパス社製、製品番号:DP72)を備える光学顕微鏡(オリンパス社製、製品番号:IX70)のステージに設置し、撮像する視野を確定した後、当該ガラスボトム上の細胞にDABによる発色基質溶液(Dako社製、製品番号:K1390)を添加し、添加時点から0分後(添加直後)、0.5分後、1分後、及び3分後の透過光画像を取得した。得られた画像中の着目した任意の細胞について、画像処理ソフトcellSens(オリンパス社)を用いて、グレースケールで表示した色成分を256階調で数値化した。各細胞の透過率として、各細胞を構成する全画素の平均階調数値を算出した。   Thereafter, the cell culture container of each cell specimen is placed on the stage of an optical microscope (Olympus, product number: IX70) equipped with an imaging device (Olympus, product number: DP72), and the visual field to be imaged is determined. A DAB chromogenic substrate solution (manufactured by Dako, product number: K1390) was added to the cells on the glass bottom, 0 minutes after the addition (immediately after the addition), 0.5 minutes, 1 minute, and 3 A transmitted light image after a minute was acquired. For any cell of interest in the obtained image, the color component displayed in gray scale was digitized with 256 gradations using image processing software cellSens (Olympus). As the transmittance of each cell, the average gradation value of all pixels constituting each cell was calculated.

各細胞標本について取得された透過光画像を図1に示す。顕微鏡観察の結果、ネガティブコントロールには、陽性の細胞(抗Ki−67抗体による免疫染色された細胞)は見られなかった(図1の上段)。一方、ポジティブコントロールは、ほぼ全ての細胞で陽性であった(図1の中段)。また、サンプルでは、DAB添加直後(0分後)でもパパニコロウ染色による色が確認され、反応時間の経過と共に、バックグラウンドとなるパパニコロウ染色の上からさらに呈色する様子が観察された(図1の下段)。   The transmitted light image acquired about each cell specimen is shown in FIG. As a result of microscopic observation, no positive cells (cells immunostained with anti-Ki-67 antibody) were found in the negative control (upper row in FIG. 1). On the other hand, the positive control was positive in almost all cells (middle of FIG. 1). In addition, in the sample, the color due to Papanicolaou staining was confirmed immediately after DAB addition (after 0 minutes), and as the reaction time passed, the appearance of further coloration from above the background Papanicolaou staining was observed (FIG. 1). Bottom).

図2に、各細胞について、酵素反応時間ごとの階調数をプロットした図を示す。ネガティブコントロールの細胞(Cell 1)とサンプルの4細胞のうちの1つ(Cell 5)は、階調数の変化がほとんど見られなかった。一方、ポジティブコントロールの全細胞(Cell 2〜4)及びサンプルの残る3細胞(Cell 6〜8)は、時間の経過に伴った階調数の増大が見られた。   FIG. 2 shows a plot of the number of gradations for each enzyme reaction time for each cell. The negative control cell (Cell 1) and one of the 4 cells of the sample (Cell 5) showed almost no change in the number of gradations. On the other hand, the positive number of cells (Cells 2 to 4) and the remaining 3 cells (Cells 6 to 8) of the sample showed an increase in the number of gradations with the passage of time.

図2から、各細胞について、酵素反応時間0〜1分間における階調数の変化量を近似直線で表し、傾きを比較した。0〜1分間における階調数の変化から求められる近似式の傾き及び切片を表1に示す。この結果、ポジティブコントロールに見られた10〜40程度の大きさの傾きは、パパニコロウ染色によるバックグラウンドを有するサンプル(Cell 6〜8)においても見られた。また、ポジティブコントロールにおいて、Ki−67の低発現細胞(Cell 2、傾き13)と中発現細胞(Cell 3、傾き20)と高発現細胞(Cell 4、傾き46)で傾きに差が見られたのと同様に、サンプルにおいても、低発現細胞(Cell 6、傾き9)と中発現細胞(Cell 7、傾き25)と高発現細胞(Cell 8、傾き34)の細胞で、傾きに差が生じた。この結果から、本発明に係る発現量評価方法により、色素染色された細胞についても、標的タンパク質の相対的な発現量を評価できることが明らかである。   From FIG. 2, for each cell, the amount of change in the number of gradations in the enzyme reaction time of 0 to 1 minute was represented by an approximate line, and the slopes were compared. Table 1 shows the slope and intercept of the approximate expression obtained from the change in the number of gradations in 0 to 1 minute. As a result, the inclination of about 10 to 40 seen in the positive control was also observed in the samples (Cells 6 to 8) having a background by Papanicolaou staining. Further, in the positive control, there was a difference in slope between the low expression cells (Cell 2, slope 13), the medium expression cells (Cell 3, slope 20) and the high expression cells (Cell 4, slope 46) of Ki-67. Similarly to the above, in the sample, there is a difference in slope between the low expression cell (Cell 6, slope 9), the medium expression cell (Cell 7, slope 25) and the high expression cell (Cell 8, slope 34). It was. From this result, it is clear that the relative expression level of the target protein can be evaluated for the dye-stained cells by the expression level evaluation method according to the present invention.

本発明に係る発現量評価方法は、酵素標識抗体の酵素反応による発色以外の色がバックグラウンドとなる細胞についても、酵素抗体染色法により標的タンパク質発現量を精度よく評価し得るため、特に、色素染色と免疫染色の両方を行う細胞診や組織診断等の病理分野において好適に利用される。   Since the expression level evaluation method according to the present invention can accurately evaluate the target protein expression level by the enzyme antibody staining method even for cells whose background is a color other than the color developed by the enzyme reaction of the enzyme-labeled antibody, It is suitably used in pathological fields such as cytodiagnosis and tissue diagnosis for performing both staining and immunostaining.

Claims (4)

(a)細胞試料中の細胞に対して、標的タンパク質と特異的に結合する酵素標識抗体又は酵素標識抗体複合体を用いた抗原抗体反応を行う工程と、
(b)前記工程(a)の後、前記細胞試料中の細胞に発色基質を加えて、酵素反応により発色させる工程と、
(c)前記工程(b)中、発色基質添加直後の時点を含む、発色基質添加後の少なくとも2以上の時点において、前記細胞試料中の細胞の透過光画像を取得する工程と、
(d)前記工程(c)において取得した2以上の透過光画像に基づき、各細胞における透過率の経時的変化を調べる工程と、
(e)前記工程(d)において求めた透過率の経時的変化に基づき、各細胞の前記標的タンパク質の発現量を評価する工程と、
を有し、
前記工程(d)において、透過率の経時的変化を、透過率の変化量が予め規定された一定量に達するために要する酵素反応時間として求めることを特徴とする、細胞の標的タンパク質の発現量の評価方法。
(A) performing an antigen-antibody reaction using an enzyme-labeled antibody or enzyme-labeled antibody complex that specifically binds to a target protein on cells in a cell sample;
(B) after the step (a), adding a chromogenic substrate to the cells in the cell sample and causing a color to develop by an enzymatic reaction;
(C) obtaining a transmitted light image of cells in the cell sample at at least two or more time points after the addition of the chromogenic substrate, including the time point immediately after the addition of the chromogenic substrate in the step (b);
(D) based on two or more transmitted light images acquired in the step (c), examining the change over time of the transmittance in each cell;
(E) a step of evaluating the expression level of the target protein in each cell based on the change over time of the transmittance determined in the step (d);
I have a,
In the step (d), the expression amount of the target protein of the cell, characterized in that the change in permeability over time is determined as an enzyme reaction time required for the change in permeability to reach a predetermined amount. Evaluation method.
(a)細胞試料中の細胞に対して、標的タンパク質と特異的に結合する酵素標識抗体又は酵素標識抗体複合体を用いた抗原抗体反応を行う工程と、  (A) performing an antigen-antibody reaction using an enzyme-labeled antibody or enzyme-labeled antibody complex that specifically binds to a target protein on cells in a cell sample;
(b)前記工程(a)の後、前記細胞試料中の細胞に発色基質を加えて、酵素反応により発色させる工程と、(B) after the step (a), adding a chromogenic substrate to the cells in the cell sample and causing a color to develop by an enzymatic reaction;
(c)前記工程(b)中、発色基質添加直後の時点を含む、発色基質添加後の少なくとも2以上の時点において、前記細胞試料中の細胞の透過光画像を取得する工程と、(C) obtaining a transmitted light image of cells in the cell sample at at least two or more time points after the addition of the chromogenic substrate, including the time point immediately after the addition of the chromogenic substrate in the step (b);
(d)前記工程(c)において取得した2以上の透過光画像に基づき、各細胞における透過率の経時的変化を調べる工程と、(D) based on two or more transmitted light images acquired in the step (c), examining the change over time of the transmittance in each cell;
(e)前記工程(d)において求めた透過率の経時的変化に基づき、各細胞の前記標的タンパク質の発現量を評価する工程と、(E) a step of evaluating the expression level of the target protein in each cell based on the change over time of the transmittance determined in the step (d);
を有し、Have
前記工程(d)において、透過率の経時的変化を、透過率当たりの酵素反応時間変化率として求めることを特徴とする細胞の標的タンパク質の発現量の評価方法。  A method for evaluating the expression level of a target protein in a cell, wherein, in the step (d), a change in permeability over time is determined as a rate of change in enzyme reaction time per permeability.
前記工程(b)の前に、前記細胞試料中の細胞が、色素により染色されている、請求項1または請求項2に記載の細胞の標的タンパク質の発現量の評価方法。 The method for evaluating the expression level of a target protein in a cell according to claim 1 or 2 , wherein cells in the cell sample are stained with a dye before the step (b). 前記透過率が、画像の階調数として表される、請求項1または請求項2に記載の細胞の標的タンパク質の発現量の評価方法。 The method for evaluating the expression level of a target protein in a cell according to claim 1 or 2, wherein the transmittance is expressed as the number of gradations of an image.
JP2013127018A 2013-06-17 2013-06-17 Method for evaluating the expression level of target protein in cells Expired - Fee Related JP6202893B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013127018A JP6202893B2 (en) 2013-06-17 2013-06-17 Method for evaluating the expression level of target protein in cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013127018A JP6202893B2 (en) 2013-06-17 2013-06-17 Method for evaluating the expression level of target protein in cells

Publications (2)

Publication Number Publication Date
JP2015001480A JP2015001480A (en) 2015-01-05
JP6202893B2 true JP6202893B2 (en) 2017-09-27

Family

ID=52296079

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013127018A Expired - Fee Related JP6202893B2 (en) 2013-06-17 2013-06-17 Method for evaluating the expression level of target protein in cells

Country Status (1)

Country Link
JP (1) JP6202893B2 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5161052B2 (en) * 2008-12-04 2013-03-13 オリンパス株式会社 Microscope system, specimen observation method and program
JP3896418B2 (en) * 2001-09-19 2007-03-22 東西産業貿易株式会社 Stunning device
US8080423B2 (en) * 2004-08-05 2011-12-20 Asahi Kasei Pharma Corporation Reagent containing protease reaction promoter and/or colorant stabilizer
JP2008022728A (en) * 2006-07-19 2008-02-07 Matsushita Electric Ind Co Ltd Liquid sample analysis technique and liquid sample analysis sensor
JP5698131B2 (en) * 2009-06-26 2015-04-08 国立大学法人東北大学 Imported lymphatic inflow detection method and specific cell identification method
US20140154717A1 (en) * 2011-03-31 2014-06-05 Hirosaki University Method for detecting cancer cell using fluorescently labeled l-glucose derivative, and cancer cell-imaging agent comprising fluorescently labeled l-glucose derivative

Also Published As

Publication number Publication date
JP2015001480A (en) 2015-01-05

Similar Documents

Publication Publication Date Title
Mebratie et al. Review of immunohistochemistry techniques: Applications, current status, and future perspectives
Li et al. High-dimensional cell-level analysis of tissues with Ce3D multiplex volume imaging
JP5631999B2 (en) System and method for generating bright field images using fluorescent images
US20060041385A1 (en) Method of quantitating proteins and genes in cells using a combination of immunohistochemistry and in situ hybridization
Wasserman et al. High concordance of a closed-system, RT-qPCR breast cancer assay for HER2 mRNA, compared to clinically determined immunohistochemistry, fluorescence in situ hybridization, and quantitative immunofluorescence
Jafree et al. Tissue clearing and deep imaging of the kidney using confocal and two-photon microscopy
US10718694B2 (en) Counterstains for a biological sample
Soygur et al. A roadmap for three-dimensional analysis of the intact mouse ovary
US9097618B2 (en) Method for preparing cell standard
JP2021507419A (en) Systems and methods for classifying cells in tissue images based on membrane characteristics
Yang et al. Tissue preparation and immunostaining of mouse craniofacial tissues and undecalcified bone
JP6202893B2 (en) Method for evaluating the expression level of target protein in cells
Demirel et al. Comparison of sysmex UF-5000 flow cytometer and fuchs-rosenthal chamber urine sediment analysis.
JP2011133371A (en) Method for specifying degree of hair glycosylation and evaluation method using the same
Nwachokor et al. Quantitation of spatial and temporal variability of biomarkers for Barrett's Esophagus
Geuna et al. Morpho-quantitative stereological analysis of peripheral and optic nerve fibers
Siegerist et al. A super-resolution compatible workflow for highly multiplexed immunofluorescence of routinely processed kidney tissue
Christoffersen Immunohistochemical staining of human sperm cells in smears from sexual assault cases
Almasaad et al. Anatomical research based on microscopic study
Lakkundi et al. Simultaneous RNA Fluorescent In Situ Hybridization and Immunofluorescent Staining of Mouse Muscle Stem Cells on Fresh Frozen Skeletal Muscle Sections
Bayer et al. Development and validation of an assay for the characterization of SSTR2 expression on CTCs from liquid biopsies
Pearson et al. An Integrated Workflow for Three-Dimensional Visualization of Human Skeletal Muscle Stem Cell Nuclei
CN121027505A (en) A quantitative assessment method for immunohistochemical staining intensity based on fluorescent labeling
Bavisotto et al. and Methods for Assessing the Chaperonin in Extracellular
Shumanska et al. Cyclic Multiplex Immunofluorescence Workflow for Mouse Models of Parkinson’s Disease

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160401

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20170317

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170418

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170530

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20170531

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20170822

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20170829

R151 Written notification of patent or utility model registration

Ref document number: 6202893

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R151

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees